For Patients Prostate Cancer
Cancer - many diseases under one term.

Prostate Cancer

The diagnosis of cancer of the prostate (prostate carcinoma) is a great physical and psychological challenge for every patient. In addition to imaging procedures such as ultrasound and MRI examinations, prostate tissue may also have to be removed (biopsy).
Blood testing for prostate-specific antigen (PSA and free PSA) remains of great importance in assessing the course of the disease. Your urologist will consult you on this matter.

In addition, highly sensitive laboratory tests have been established that detect the genetic material of prostate tumor cells in the patient's blood. Since this genetic material carries changes that have only arisen in the tumor, this can be used to monitor the progression of the disease very precisely. It can be assessed whether the tumor has been completely removed or whether tumor cells have remained. This examination is called liquid biopsy.

More Information

In patients with advanced prostate cancer, it is important to determine whether and, if so, how long the chosen therapy will continue to work. Hormone therapies with abiraterone or enzalutamide often lose their effect after some time, with the tumor releasing a certain substance into the blood.

This is where the prostate monitor (AR/V7) comes into play. It allows us to test affected patients to see if this substance is detectable and whether the therapy needs to be adjusted accordingly! All we need is a blood sample.